Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 8912858)

Published in Cancer Res on November 15, 1996

Authors

M R Hamblin1, J L Miller, T Hasan

Author Affiliations

1: Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.

Articles citing this

Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med (2011) 2.76

The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer (2005) 1.22

Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res (2001) 1.18

Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer (2000) 1.08

Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer. Immunology (2007) 1.08

Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates. Br J Cancer (2001) 0.99

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer (1997) 0.99

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy. Br J Cancer (2003) 0.96

Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer. Br J Cancer (2000) 0.90

New photosensitizers for photodynamic therapy. Biochem J (2016) 0.87

Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results. Isr J Chem (2012) 0.83

Targets and mechanisms of photodynamic therapy in lung cancer cells: a brief overview. Cancers (Basel) (2011) 0.80

Bioluminescence-activated deep-tissue photodynamic therapy of cancer. Theranostics (2015) 0.80

Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy. Bioanalysis (2013) 0.79

Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities. Pharmaceuticals (Basel) (2010) 0.79

Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections. Front Microbiol (2015) 0.78

Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates. Macromol Biosci (2012) 0.78

Nanotechnology for photodynamic therapy: a perspective from the Laboratory of Dr. Michael R. Hamblin in the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School. Nanotechnol Rev (2015) 0.75

Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. Nanoscale (2016) 0.75

Articles by these authors

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98

The effect on blood-pressure of organ extracts. J Physiol (1911) 2.24

Photoincorporation of tetracycline into Escherichia coli ribosomes. Identification of the major proteins photolabeled by native tetracycline and tetracycline photoproducts and implications for the inhibitory action of tetracycline on protein synthesis. Biochemistry (1983) 2.07

Fluorescent treponemal antibodies in fractionated syphilitic sera. The immunoglobulin class. Arch Dermatol (1969) 2.06

pepM is an essential gene in Salmonella typhimurium. J Bacteriol (1989) 1.85

Three-dimensional miniature endoscopy. Nature (2006) 1.82

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol (2001) 1.82

Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother (1998) 1.79

Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71

N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66

Effect of speaking rate on the perceptual structure of a phonetic category. Percept Psychophys (1989) 1.59

Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal. J Mol Biol (1999) 1.57

Articulation rate and its variability in spontaneous speech: a reanalysis and some implications. Phonetica (1984) 1.52

The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51

In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer (2009) 1.51

Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol (1992) 1.50

The TPI and FTA-ABS tests in treated late syphilis. JAMA (1968) 1.50

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49

Some effects of later-occurring information on the perception of stop consonant and semivowel. Percept Psychophys (1979) 1.47

Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45

A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer (1994) 1.43

Amplification and purification of the bacteriophage Mu encoded B transposition protein. J Biol Chem (1985) 1.43

The North American experience with photopheresis. Ther Apher (1999) 1.42

Epidurals redefined in analgesia and anesthesia: a distinction with a difference. J Obstet Gynecol Neonatal Nurs (1996) 1.42

Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem Photobiol (1994) 1.42

GnRH agonists: gonadorelin, leuprolide and nafarelin. Am Fam Physician (1991) 1.40

Marrow aplasia and sulindac. Ann Intern Med (1980) 1.40

GFPcre fusion vectors with enhanced expression. Anal Biochem (1999) 1.39

Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39

Finasteride for benign prostatic hyperplasia. Am Fam Physician (1992) 1.38

Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry (1990) 1.36

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry (1997) 1.36

Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc Natl Acad Sci U S A (1986) 1.36

Phonetic prototypes: influence of place of articulation and speaking rate on the internal structure of voicing categories. J Acoust Soc Am (1992) 1.35

Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res (1999) 1.31

Primary structure of phage mu transposase: homology to mu repressor. Proc Natl Acad Sci U S A (1985) 1.30

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30

Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology (1994) 1.27

Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology (1996) 1.25

Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol (1995) 1.24

Treated late syphilis: immunoglobulin class of antibodies reactive with Treponema pallidum. J Invest Dermatol (1969) 1.24

Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem (1997) 1.23

Erosive arthritis associated with apatite crystal deposition. Arthritis Rheum (1981) 1.22

Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem Photobiol (1998) 1.21

Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood (1982) 1.20

Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res (2000) 1.20

Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J Virol (1996) 1.20

Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res (2001) 1.18

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer (2006) 1.16

Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun (2005) 1.16

Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res (2001) 1.15

Gene therapy for human hemoglobinopathies. Proc Soc Exp Biol Med (1993) 1.15

Interconversion of metarhodopsins I and II: a branched photointermediate decay model. Biochemistry (1990) 1.14

Photodynamic treatment of rheumatoid and inflammatory arthritis. Photochem Photobiol (1996) 1.13

Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol (2012) 1.12

Isolation and mapping of Mu nu mutants which grow in him mutants of E. coli. Virology (1982) 1.12

Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res (1991) 1.12

Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br J Cancer (1998) 1.12

Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res (1998) 1.11

Scavenger-receptor targeted photodynamic therapy. Photochem Photobiol (2000) 1.10

Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res (1997) 1.10

Plasmin inhibition of thrombin-induced platelet aggregation. Thromb Diath Haemorrh (1975) 1.09

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol (2008) 1.09

Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer (2000) 1.08

Gene expression in proliferating human erythroid cells. Genomics (1999) 1.08

Psoriatic acro-osteolysis without arthritis. A case study. J Bone Joint Surg Am (1971) 1.07

Photoluminescence spectroscopy of carbon nanotube bundles: evidence for exciton energy transfer. Phys Rev Lett (2007) 1.07

BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells. Br J Cancer (1999) 1.07

A truncated form of the bacteriophage Mu B protein promotes conservative integration, but not replicative transposition, of Mu DNA. Cell (1985) 1.07

Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library. J Immunol Methods (2001) 1.06

Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res (1996) 1.06

The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates. Photochem Photobiol (1997) 1.06

Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis (1987) 1.06

Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol (2010) 1.06

Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology (1994) 1.06

Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice. Int J Cancer (1996) 1.05

Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J Clin Endocrinol Metab (1995) 1.04

Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Res (1993) 1.04

Effects of syllable-initial voicing and speaking rate on the temporal characteristics of monosyllabic words. J Acoust Soc Am (1999) 1.04

Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem Photobiol (1996) 1.03

Contextual effects in infant speech perception. Science (1980) 1.03

Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol (1995) 1.03

Sensitive light scattering probe of enzymatic processes in retinal rod photoreceptor membranes. Proc Natl Acad Sci U S A (1984) 1.02

Erythroderma: a follow-up of fifty cases. J Am Acad Dermatol (1983) 1.02

Drug review articles and industry ties. Am J Health Syst Pharm (1997) 1.02

On the role of visual rate information in phonetic perception. Percept Psychophys (1985) 1.01

In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med (1995) 1.01

von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest (1983) 1.01

The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J Photochem Photobiol B (1995) 1.00

Integrin-mediated adhesion and signalling in ovarian cancer cells. Cell Signal (1998) 1.00

Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein. J Virol Methods (2000) 1.00

Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer (1994) 1.00

Characterization of the megakaryocyte secretory response: studies of continuously monitored release of endogenous ATP. Blood (1983) 1.00

Motivators of health seeking behavior in urban African-American men: an exploration of triggers and barriers. J Natl Black Nurses Assoc (2000) 0.99

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer (2002) 0.99

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season. Clin Exp Immunol (2007) 0.99

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer (1997) 0.99

Identification of the dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood (2000) 0.98